By
admin
#Abuse, #Advertising, #Advertising/Public Relations/Marketing, #article_normal, #beverages, #Business, #Business/Consumer Services, #C&E Industry News Filter, #canabis, #Cannabis, #Cantourage, #Cantourage Group SE, #Community, #Consumer Products, #consumer services, #Content Types, #Corporate, #Corporate Actions, #Corporate Changes, #Corporate Funding, #Corporate/Industrial News, #DE:HIGH, #debut, #drug, #Drug/Substance Use/Abuse, #Factiva Filters, #food, #Food/Beverages/Tobacco, #Frankfurt, #general news, #germany, #government policy, #industrial news, #Initial Public Offerings, #Maker, #Marijuana, #Marijuana Products, #marijuana use, #Marijuana Use/Abuse, #Marketing, #Medical, #Political, #Political/General News, #Public Relations, #regulation, #Regulation/Government Policy, #Share Capital, #Social Issues, #Society, #Society/Community, #Stock Listings, #substance use, #surges, #Tobacco
Medical cannabis maker Cantourage soared in its debut in Frankfurt on Friday.
With the ticker symbol “HIGH,” shares of the Berlin-based company
HIGH,
rose as high as €19.70 after the IPO was priced at €6.48 per share.
Cantourage distributes products across Europe and the U.K. and maintains 38 partnerships with suppliers from 17 countries.
Germany last month passed a law to allow recreational cannabis purchases.
